May 20, 2020 / 9:26 PM / 8 days ago

BRIEF-Neurobo Pharmaceuticals Reports Q1 Loss Per Share Of $0.30

May 20 (Reuters) - Neurobo Pharmaceuticals Inc:

* NEUROBO PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.30

* NEUROBO PHARMACEUTICALS - PLAN TO SUBMIT INVESTIGATIONAL NEW DRUG APPLICATION TO FDA FOR NB-02 AND TO INITIATE PHASE 1 TRIAL IN Q1 OF NEXT YEAR

* NEUROBO PHARMACEUTICALS - CONTINUE TO EXPECT A REPLY FROM FDA IN Q2 REGARDING REMOVAL OF PARTIAL CLINICAL HOLD FOR GEMCABENE

* NEUROBO PHARMA - EXPECTS CASH POSITION, INCLUDING NET PROCEEDS FROM APRIL REGISTERED DIRECT COMMON STOCK OFFERING, TO FUND OPERATIONS THROUGH Q1 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below